Diabetes technology

Real‐World Experience With Control‐IQ Technology in Saudi Children With Insulin‐Dependent Diabetes: A Single‐Center Observational Study

Pediatr DiabetesPublished Prospective observational study

Authors' conclusion

The findings demonstrated that Control-IQ technology is both effective and safe in improving glycemic outcomes in children with insulin-dependent diabetes in a real-world clinical setting. However, successful implementation requires comprehensive training and continuous support.

Study context

Population
Children aged 2–14 years with insulin-dependent diabetes transitioning from MDI to Control-IQ, King Faisal Specialist Hospital and Research Centre (KFSHRC) diabetes clinic, Saudi Arabia; median age 11 years; 82% history of severe hypoglycaemia44 boys · 56 girls
Participants
100 children
Exposure
Control-IQ automated insulin delivery (AID) after transition from MDI vs baseline
Outcome
Change in HbA1c
Follow-up
6 months after initiating Control-IQ
Methodological detailssingle-centre, real-world
  • Single-centre
  • Real-world

Main finding

As reported in the abstract

Median HbA1c, baseline to 6 months

Median HbA1c baseline → 6 months

9.2% to 6.9%

Change in median HbA1c

−25.0%

p < 0.001

Observational data: associations, not effects.

Further findings

Daily insulin dose · 6 months

Reduction in daily insulin dose
24.4%

Time in range (TIR) (70-180 mg/dL)

TIR baseline → follow-up
45.6% to 68.8%
Change in TIR
+23.2%; p < 0.001

Time in significant hypoglycaemia (<54 mg/dL)

Decrease in time <54 mg/dL
88.9%; p < 0.001

TIR targets achieved · 6 months

Achieved ≥60% TIR
83%
Achieved ≥70% TIR
54%

Adherence and engagement

Adherence and engagement were high; no discontinuations

Safety

Safety · 6 months

Mild/moderate ketoacidosis due to technical issues in the Control-IQ
3%
No severe hypoglycemia or discontinuations

Original publication

Real‐World Experience With Control‐IQ Technology in Saudi Children With Insulin‐Dependent Diabetes: A Single‐Center Observational Study. Pediatr Diabetes. Published 1 March 2026. doi:10.1155/pedi/6113065

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.